Solventum (FRA:KB7) Debt-to-Equity : 2.71 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Solventum Debt-to-Equity?

Solventum's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €191 Mil. Solventum's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €7,459 Mil. Solventum's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €2,826 Mil. Solventum's debt to equity for the quarter that ended in Dec. 2024 was 2.71.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Solventum's Debt-to-Equity or its related term are showing as below:

FRA:KB7' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.71 Med: 1.71 Max: 2.71
Current: 2.71

During the past 5 years, the highest Debt-to-Equity Ratio of Solventum was 2.71. The lowest was 0.71. And the median was 1.71.

FRA:KB7's Debt-to-Equity is ranked worse than
74.96% of 695 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs FRA:KB7: 2.71

Solventum Debt-to-Equity Historical Data

The historical data trend for Solventum's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum Debt-to-Equity Chart

Solventum Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

N/A

0.71

2.71

Solventum Quarterly Data
	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial								0.71	2.16	2.90	2.54	2.71

Competitive Comparison of Solventum's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Solventum's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Solventum's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Solventum's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Solventum's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Solventum Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Solventum's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(191	+	7458.55)	/	2825.845
	=	2.71

Solventum's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(191	+	7458.55)	/	2825.845
	=	2.71

Solventum (FRA:KB7) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Solventum Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Solventum's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Solventum Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (FRA:KB7) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

SOLV:USA SOLV:Mexico

Address

2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144

Website

https://www.solventum.com/en-us/home

Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.

Solventum Headlines

No Headlines